An economic evaluation of intensive hypertension control in CKD patients: a cost-effectiveness study

Ye Seol Lee1,2, Hae-Young Lee3, Tae Hyun Kim4

  • 1Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Clinical Hypertension
|November 1, 2022
PubMed

Insights

Intensive hypertension control for chronic kidney disease (CKD) patients in Korea is economically sound. This approach increases quality-adjusted life years (QALYs) and is cost-effective for managing hypertension in CKD.

Area of Science:

  • Health Economics
  • Nephrology
  • Cardiovascular Disease Management

Background:

  • Intensive hypertension control shows potential effectiveness and economic feasibility in high cardiovascular disease (CVD) risk patients.
  • Chronic kidney disease (CKD) patients with hypertension require specific management strategies.

Purpose of the Study:

  • To conduct an economic evaluation of intensive hypertension control in Korean CKD patients.
  • To compare the cost-effectiveness of intensive versus standard hypertension control in this population.

Main Methods:

  • A Markov decision model was employed to compare costs and effectiveness.
  • Model parameters were derived from Korean National Health Insurance Service (NHIS) data and existing literature.
  • Sensitivity analysis was performed to assess the robustness of the findings.

Main Results:

  • Intensive hypertension control in CKD patients incurs higher costs but yields increased quality-adjusted life years (QALYs).
  • The incremental cost-effectiveness ratio (ICER) was projected at $18,126 per QALY.
  • Sensitivity analysis confirmed the robustness of the economic evaluation.

Conclusions:

  • Intensive hypertension control is an economically sound strategy for CKD patients in Korea.
  • Findings provide valuable insights for clinicians and policymakers in hypertension management for CKD.
  • This approach supports improved health outcomes and resource allocation.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
70
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
42
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
39
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
40